https://doi.org/10.1016/j.mayocp.2024.07.006
D
Diego Añazco
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
311
Citations
9
h-index
9
i10-index
Diego Añazco is an academic researcher from WinnMed. The author has contributed to research in topics: Diabetes Treatment and Management & Diet and metabolism studies & Pharmacology and Obesity Treatment. The author has an h-index of 9, co-authored 62 publications.
ORCID: 0000-0003-1829-7001Papers by this author
worksEffect of Tirzepatide on Body Weight and Diabetes Control in Adults With Type 1 Diabetes and Overweight or Obesity
2024 · Mayo Clinic Proceedings · 20 citations
Weight-centric prevention of cancer
2024 · Obesity Pillars · 4 citations
https://doi.org/10.1016/j.obpill.2024.100106
1283 SATIATION TESTING AND A SURROGATE MACHINE-LEARNING ASSISTED GENE RISK SCORE BIOMARKER PREDICT DIFFERENTIAL RESPONSES TO LIFESTYLE INTERVENTIONS: A POST-HOC ANALYSIS OF A SINGLE CENTER, NON-RANDOMIZED CLINICAL TRIAL
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)01190-9
983 SHORT- AND LONG-TERM GUT MUCOSAL ADAPTATIONS TO DIETINDUCED WEIGHT LOSS COMPARED TO ROUX-EN-Y-INDUCED WEIGHT LOSS IN PATIENTS WITH OBESITY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)01032-1
Sa1951 CLINICAL PARAMETERS ASSOCIATED WITH SEMAGLUTIDE INTOLERANCE IN PATIENTS WITH DIABETES AND OBESITY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)01828-6
EFFICACY OF ANTI-OBESITY MEDICATIONS IN PATIENTS WITH LEPTIN-MELANOCORTIN PATHWAY HETEROZYGOUS VARIANTS POST-ENDOSCOPIC TRANSORAL OUTLET REDUCTION IN ROUX-EN-Y GASTRIC BYPASS
2024 · Gastrointestinal Endoscopy · 0 citations
https://doi.org/10.1016/j.gie.2024.04.762
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat